Luka Dončić: Everything you need to know

Luka Dončić

#77 PG

Los Angeles Lakers

Status

OUT - Hamstring - Strain Expected Return: 2026-05-03

STATS

Career Averages

PTS

REB

AST

BLK

STL

29.2

8.5

8.2

0.5

1.3

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	64	64	35.8	33.5	7.7	8.3	0.5	1.6	4.0	34	8	4.0	10.8	36.6%	6.9	11.9	57.5%	10.8	22.8	47.6%	7.9	10.1	78.0%	0.6	7.1	2.4	2.1	+187	61.6%
2024-25	50	50	35.4	28.2	8.2	7.7	0.4	1.8	3.6	21	5	3.5	9.6	36.8%	5.7	10.9	52.2%	9.2	20.5	45.0%	6.2	7.9	78.2%	0.8	7.4	2.5	2.1	+344	58.7%
2023-24	70	70	37.5	33.9	9.2	9.8	0.5	1.4	4.0	49	21	4.1	10.6	38.2%	7.4	13.0	57.3%	11.5	23.6	48.7%	6.8	8.7	78.6%	0.8	8.4	2.1	2.4	+319	61.7%
2022-23	66	66	36.2	32.4	8.6	8.0	0.5	1.4	3.6	36	10	2.8	8.2	34.2%	8.1	13.8	58.8%	10.9	22.0	49.6%	7.8	10.5	74.2%	0.8	7.8	2.5	2.2	+128	60.9%
2021-22	65	65	35.4	28.4	9.1	8.7	0.6	1.2	4.5	44	10	3.1	8.8	35.3%	6.8	12.8	52.8%	9.9	21.6	45.7%	5.6	7.5	74.4%	0.9	8.3	2.2	1.9	+146	57.1%
2020-21	66	66	34.3	27.7	8.0	8.6	0.5	1.0	4.3	26	11	2.9	8.3	35.0%	6.9	12.2	56.7%	9.8	20.5	47.9%	5.2	7.1	73.0%	0.8	7.2	2.3	2.0	+164	58.7%
2019-20	61	61	33.6	28.8	9.4	8.8	0.2	1.0	4.3	39	17	2.8	8.9	31.6%	6.7	11.7	57.4%	9.5	20.6	46.3%	7.0	9.2	75.8%	1.3	8.1	2.5	2.1	+253	58.5%
2018-19	72	72	32.2	21.2	7.8	6.0	0.3	1.1	3.4	24	8	2.3	7.1	32.7%	4.7	9.3	50.3%	7.0	16.5	42.7%	4.8	6.7	71.3%	1.2	6.6	1.9	1.7	-118	54.5%
Career	514	514	35.0	29.2	8.5	8.2	0.5	1.3	4.0	273	90	3.2	9.0	35.2%	6.7	12.0	55.6%	9.8	21.0	46.9%	6.4	8.5	75.5%	0.9	7.6	2.3	2.1	+1423	59.2%

Career Averages

PTS

REB

AST

BLK

STL

30.9

9.2

7.8

0.5

1.6

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	5	5	41.6	30.2	7.0	5.8	0.6	1.0	4.0	1	0	3.2	9.2	34.8%	6.2	11.6	53.4%	9.4	20.8	45.2%	8.2	9.2	89.1%	0.4	6.6	3.2	1.5	-24	60.8%
2023-24	22	22	40.9	28.9	9.5	8.1	0.4	1.9	4.1	16	7	3.1	9.6	32.2%	7.1	13.3	53.6%	10.2	22.9	44.6%	5.3	7.0	76.5%	0.7	8.7	2.5	2.0	+97	55.6%
2021-22	15	15	36.8	31.7	9.8	6.4	0.6	1.8	3.9	10	0	3.4	9.9	34.5%	7.3	13.6	53.4%	10.7	23.5	45.5%	6.9	9.0	77.0%	0.7	9.1	2.9	1.6	+31	57.7%
2020-21	7	7	40.1	35.7	7.9	10.3	0.4	1.3	4.6	4	1	4.4	10.9	40.8%	9.3	17.1	54.2%	13.7	28.0	49.0%	3.9	7.3	52.9%	0.6	7.3	2.4	2.3	+7	57.2%
2019-20	6	6	35.8	31.0	9.8	8.7	0.5	1.2	5.2	2	2	2.7	7.3	36.4%	8.0	14.0	57.1%	10.7	21.3	50.0%	7.0	10.7	65.6%	0.7	9.2	2.8	1.7	-38	59.6%
Career	55	55	39.2	30.9	9.2	7.8	0.5	1.6	4.2	33	10	3.3	9.5	34.7%	7.5	13.8	54.0%	10.8	23.3	46.1%	6.0	8.2	73.7%	0.7	8.5	2.7	1.8	+73	57.3%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/14	PHX	L 113-104	22	25	7	4	0	0	5	8	4	50.0%	7	3	42.9%	15	7	46.7%	9	7	77.8%	3	4	0.8	+11	3	23	65.9%
Preseason Totals			22.4	25.0	7.0	4.0	0.0	0.0	5.0	8.0	4.0	50.0%	7.0	3.0	42.9%	15.0	7.0	46.7%	9.0	7.0	77.8%	3.0	4.0	0.8	+11	3.0	26.0	65.9%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/2	OKC	L 139-96	25	12	4	7	0	1	6	7	1	14.3%	3	2	66.7%	10	3	30.0%	6	5	83.3%	0	4	1.2	-25	0	13	47.5%
3/31	CLE	W 127-113	33	42	5	12	0	2	0	13	6	46.2%	13	7	53.8%	26	13	50.0%	10	10	100.0%	0	5	0.0	+21	4	51	69.1%
3/27	BKN	W 116-99	38	41	8	3	1	3	5	10	5	50.0%	15	10	66.7%	25	15	60.0%	6	6	100.0%	2	6	0.6	+19	5	39	74.2%
3/25	IND	W 137-130	37	43	6	7	0	1	5	11	4	36.4%	19	11	57.9%	30	15	50.0%	10	9	90.0%	1	5	1.4	+6	5	38	62.5%
3/23	DET	L 113-110	38	32	7	6	0	3	3	13	3	23.1%	16	8	50.0%	29	11	37.9%	8	7	87.5%	1	6	2.0	+7	1	30	49.2%
3/21	ORL	W 105-104	38	33	5	8	1	4	4	13	3	23.1%	17	9	52.9%	30	12	40.0%	9	6	66.7%	1	4	2.0	+10	2	31	48.6%
3/19	MIA	W 134-126	37	60	7	3	0	5	2	17	9	52.9%	13	9	69.2%	30	18	60.0%	19	15	78.9%	1	6	1.5	+7	1	66	78.2%
3/18	HOU	W 124-116	37	40	9	10	0	1	5	17	7	41.2%	8	5	62.5%	25	12	48.0%	14	9	64.3%	0	9	2.0	+2	3	43	64.2%
3/16	HOU	W 100-92	39	36	6	4	0	2	4	12	4	33.3%	15	10	66.7%	27	14	51.9%	5	4	80.0%	0	6	1.0	+6	1	33	61.6%
3/14	DEN	W 127-125	43	30	11	13	3	1	6	14	4	28.6%	12	6	50.0%	26	10	38.5%	9	6	66.7%	0	11	2.2	-4	3	37	50.1%
3/12	CHI	W 142-130	36	51	10	9	1	3	1	14	9	64.3%	17	8	47.1%	31	17	54.8%	9	8	88.9%	0	10	9.0	+15	3	60	72.9%
3/10	MIN	W 120-106	34	31	11	11	1	2	4	12	4	33.3%	12	7	58.3%	24	11	45.8%	6	5	83.3%	0	11	2.8	+20	0	42	58.2%
3/8	NYK	W 110-97	38	35	8	4	0	2	6	16	5	31.3%	9	6	66.7%	25	11	44.0%	10	8	80.0%	0	8	0.7	+14	3	30	59.5%
3/6	IND	W 128-117	31	44	9	5	2	3	3	14	7	50.0%	11	7	63.6%	25	14	56.0%	10	9	90.0%	0	9	1.7	+20	1	53	74.8%
3/5	DEN	L 120-113	40	27	11	7	0	4	3	10	3	30.0%	14	8	57.1%	24	11	45.8%	4	2	50.0%	1	10	2.3	+0	3	31	52.4%
3/3	NOP	W 110-101	37	27	10	7	1	0	7	10	3	30.0%	12	7	58.3%	22	10	45.5%	5	4	80.0%	0	10	1.0	+1	2	27	55.8%
3/1	SAC	W 128-104	29	28	5	9	1	1	1	8	4	50.0%	8	6	75.0%	16	10	62.5%	7	4	57.1%	0	5	9.0	+18	1	39	73.4%
2/28	GSW	W 129-101	29	26	6	8	1	1	2	9	4	44.4%	8	5	62.5%	17	9	52.9%	4	4	100.0%	0	6	4.0	+26	2	32	69.3%
2/26	PHX	L 113-110	39	41	8	8	0	2	3	11	6	54.5%	10	6	60.0%	21	12	57.1%	12	11	91.7%	0	8	2.7	+9	1	52	78.0%
2/24	ORL	L 110-109	37	22	9	15	1	0	2	10	2	20.0%	14	6	42.9%	24	8	33.3%	9	4	44.4%	1	8	7.5	+1	3	26	39.3%
2/22	BOS	L 111-89	32	25	5	3	1	0	2	7	4	57.1%	15	5	33.3%	22	9	40.9%	6	3	50.0%	0	5	1.5	-21	4	18	50.7%
2/20	LAC	W 125-122	37	38	6	11	1	3	2	14	8	57.1%	11	3	27.3%	25	11	44.0%	11	8	72.7%	1	5	5.5	+6	3	46	63.7%
2/5	PHI	W 119-115	15	10	4	2	0	0	5	4	0	0.0%	6	3	50.0%	10	3	30.0%	4	4	100.0%	0	4	0.4	-10	0	6	42.5%
2/3	BKN	W 125-109	28	24	6	5	0	1	5	11	4	36.4%	7	4	57.1%	18	8	44.4%	6	4	66.7%	1	5	1.0	+19	1	21	58.1%
2/1	NYK	L 112-100	36	30	15	8	0	0	3	14	5	35.7%	9	5	55.6%	23	10	43.5%	6	5	83.3%	0	15	2.7	-13	2	37	58.5%
1/30	WAS	W 142-111	30	37	11	13	0	3	5	13	6	46.2%	8	7	87.5%	21	13	61.9%	7	5	71.4%	0	11	2.6	+21	0	53	76.8%
1/28	CLE	L 129-99	29	29	5	6	0	0	2	8	3	37.5%	12	9	75.0%	20	12	60.0%	6	2	33.3%	0	5	3.0	-23	1	28	64.0%
1/26	CHI	W 129-118	38	46	7	12	0	0	3	14	8	57.1%	11	7	63.6%	25	15	60.0%	12	8	66.7%	0	7	4.0	+6	2	51	76.0%
1/24	DAL	W 116-110	39	33	8	11	1	1	5	8	3	37.5%	7	5	71.4%	15	8	53.3%	15	14	93.3%	0	8	2.2	+18	2	48	76.4%
1/22	LAC	L 112-104	39	32	11	8	0	3	1	13	3	23.1%	14	8	57.1%	27	11	40.7%	10	7	70.0%	1	10	8.0	-17	2	40	51.0%
1/20	DEN	W 115-107	35	38	13	10	0	2	3	9	3	33.3%	12	9	75.0%	21	12	57.1%	12	11	91.7%	0	13	3.3	-2	2	53	72.3%
1/18	TOR	W 110-93	33	25	2	7	1	1	4	12	5	41.7%	11	3	27.3%	23	8	34.8%	5	4	80.0%	0	2	1.8	-3	4	13	49.6%
1/15	CHA	L 135-117	35	39	3	4	0	0	1	11	6	54.5%	15	9	60.0%	26	15	57.7%	7	3	42.9%	1	2	4.0	-13	3	32	67.1%
1/13	ATL	W 141-116	33	27	5	12	1	0	7	9	5	55.6%	7	2	28.6%	16	7	43.8%	10	8	80.0%	2	3	1.7	+27	4	30	66.2%
1/12	SAC	L 124-112	36	42	7	8	0	4	4	9	2	22.2%	16	14	87.5%	25	16	64.0%	8	8	100.0%	2	5	2.0	-10	2	50	73.6%
1/9	MIL	L 105-101	36	24	9	9	0	2	3	6	4	66.7%	19	4	21.1%	25	8	32.0%	8	4	50.0%	3	6	3.0	-14	6	21	42.1%
1/7	SAS	L 107-91	38	38	10	10	0	3	7	9	2	22.2%	17	11	64.7%	26	13	50.0%	16	10	62.5%	0	10	1.4	-7	3	43	57.5%
1/6	NOP	W 111-103	37	30	2	10	1	2	5	10	3	30.0%	12	8	66.7%	22	11	50.0%	9	5	55.6%	0	2	2.0	+2	2	32	57.8%
1/4	MEM	W 120-114	38	36	9	8	1	0	3	10	4	40.0%	10	6	60.0%	20	10	50.0%	13	12	92.3%	2	7	2.7	+9	2	45	70.0%
1/2	MEM	W 128-121	37	34	6	8	0	2	6	7	1	14.3%	11	7	63.6%	18	8	44.4%	20	17	85.0%	0	6	1.3	+3	3	39	63.4%
12/30	DET	L 128-106	35	30	5	11	0	0	8	11	3	27.3%	11	6	54.5%	22	9	40.9%	13	9	69.2%	2	3	1.4	-15	3	26	54.1%
12/28	SAC	W 125-101	32	34	5	7	1	3	5	14	5	35.7%	9	6	66.7%	23	11	47.8%	8	7	87.5%	0	5	1.4	+22	3	36	64.1%
12/25	HOU	L 119-96	33	25	5	7	2	1	6	8	3	37.5%	9	6	66.7%	17	9	52.9%	7	4	57.1%	0	5	1.2	-25	2	26	62.3%
12/20	LAC	L 103-88	19	12	5	2	0	0	4	6	1	16.7%	7	3	42.9%	13	4	30.8%	5	3	60.0%	0	5	0.5	-13	1	6	39.5%
12/18	UTA	W 143-135	39	45	11	14	0	5	1	12	4	33.3%	16	10	62.5%	28	14	50.0%	16	13	81.3%	2	9	14.0	-5	2	65	64.2%
12/14	PHX	W 116-114	38	29	3	6	0	1	6	14	2	14.3%	11	5	45.5%	25	7	28.0%	14	13	92.9%	2	1	1.0	-5	3	19	46.5%
12/10	SAS	L 132-119	40	35	5	8	0	1	3	8	3	37.5%	16	8	50.0%	24	11	45.8%	14	10	71.4%	0	5	2.7	-2	5	32	58.0%
12/7	PHI	W 112-108	38	31	15	11	2	0	5	9	2	22.2%	15	7	46.7%	24	9	37.5%	14	11	78.6%	1	14	2.2	+12	1	41	51.4%
12/1	PHX	L 125-108	31	38	11	5	0	0	9	8	3	37.5%	18	12	66.7%	26	15	57.7%	5	5	100.0%	0	11	0.6	-25	2	37	67.4%
11/30	NOP	W 133-121	35	34	12	7	1	1	2	12	4	33.3%	10	5	50.0%	22	9	40.9%	14	12	85.7%	2	10	3.5	+8	0	49	60.4%
11/28	DAL	W 129-119	40	35	5	11	1	0	4	9	4	44.4%	9	6	66.7%	18	10	55.6%	11	11	100.0%	0	5	2.8	+15	4	43	76.6%
11/25	LAC	W 135-118	38	43	9	13	1	1	3	12	7	58.3%	16	7	43.8%	28	14	50.0%	11	8	72.7%	2	7	4.3	+9	4	52	65.5%
11/23	UTA	W 108-106	40	33	11	8	0	3	6	12	3	25.0%	12	7	58.3%	24	10	41.7%	12	10	83.3%	0	11	1.3	+5	2	39	56.4%
11/18	UTA	W 140-126	34	37	5	10	0	4	8	10	2	20.0%	12	9	75.0%	22	11	50.0%	16	13	81.3%	0	5	1.3	+10	4	41	63.7%
11/15	MIL	W 119-95	38	41	9	6	2	1	3	11	5	45.5%	8	4	50.0%	19	9	47.4%	20	18	90.0%	1	8	2.0	+25	1	56	73.7%
11/14	NOP	W 118-104	40	24	7	12	1	2	3	8	3	37.5%	8	3	37.5%	16	6	37.5%	13	9	69.2%	1	6	4.0	+30	1	37	55.2%
11/12	OKC	L 121-92	32	19	7	7	0	2	4	7	1	14.3%	13	6	46.2%	20	7	35.0%	7	4	57.1%	1	6	1.8	-31	3	16	41.2%
11/10	CHA	W 121-111	38	38	6	7	0	1	2	15	5	33.3%	13	9	69.2%	28	14	50.0%	5	5	100.0%	1	5	3.5	+16	4	38	62.9%
11/8	ATL	L 122-102	26	22	5	11	0	1	5	10	4	40.0%	7	3	42.9%	17	7	41.2%	6	4	66.7%	0	5	2.2	-21	2	23	56.0%
11/5	SAS	W 118-116	41	35	9	13	2	5	4	11	4	36.4%	16	5	31.3%	27	9	33.3%	17	13	76.5%	3	6	3.3	+4	5	45	50.8%
11/2	MIA	W 130-120	38	29	11	10	0	3	5	11	1	9.1%	11	8	72.7%	22	9	40.9%	12	10	83.3%	0	11	2.0	+14	1	41	53.2%
10/31	MEM	W 117-112	38	44	12	6	0	0	5	15	6	40.0%	12	8	66.7%	27	14	51.9%	13	10	76.9%	1	11	1.2	-2	3	46	67.2%
10/24	MIN	W 128-110	34	49	11	8	0	0	3	12	5	41.7%	11	9	81.8%	23	14	60.9%	19	16	84.2%	1	10	2.7	+18	4	60	78.1%
10/21	GSW	L 119-109	40	43	12	9	1	2	3	10	2	20.0%	17	15	88.2%	27	17	63.0%	10	7	70.0%	0	12	3.0	-8	1	60	68.5%
Regular Season Totals			35.8	33.5	7.7	8.3	0.5	1.6	4.0	10.8	4.0	36.6%	11.9	6.9	57.5%	22.8	10.8	47.6%	10.1	7.9	78.0%	0.6	7.1	2.1	+187	2.4	40.8	61.6%

Luka Dončić: Breaking News

ESPN's Shams Charania reported Tuesday on NBA Today that the Lakers are not expecting Doncic (hamstring) to return during the first round of the Western Conference playoffs versus Houston. Although it's not necessarily an unexpected update, it sounds like the Lakers will have to advance to the second round in order for Doncic to see the court again in 2025-26. With the superstar guard continuing to nurse a Grade 2 left hamstring strain, LeBron James should remain the focal point of Los Angeles' offense while Luke Kennard takes on an expanded role.

Doncic (hamstring) has been ruled out for Tuesday's Game 2 of the Western Conference first-round series against the Rockets. Doncic has been sidelined by a Grade 2 left hamstring strain, and, as expected, will remain out as the Lakers look to extend their series lead to 2-0. An update on Doncic and Austin Reaves' (oblique) status and potential return is likely to come in the next few days, though in the meantime Los Angeles will look to continue getting strong production from Luke Kennard, who delivered a 27-point performance in Game 1.

Doncic (hamstring) will miss at least one more week, per Khobi Price of The California Post. Doncic is still considered out indefinitely due to a Grade 2 left hamstring strain, and his status for the first round of the playoffs versus Houston remains in serious doubt. With Austin Reaves (oblique) also out indefinitely, the Lakers will have to lean more heavily on LeBron James, and Luke Kennard should continue to play a more prominent role in the backcourt as well.